Lee-Jah Chang MD
Allergy & Immunology
Director, Global Clinical Development
Join to View Full Profile
1 Medimmune WayGaithersburg, MD 20878
Phone+1 301-398-0000
Fax+1 570-957-0934
Dr. Chang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Allergy and Immunology, 2010 - 2013
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 2007 - 2010- Northwestern University The Feinberg School of MedicineClass of 2007
Certifications & Licensure
MD State Medical License 2011 - 2026
PA State Medical License 2013 - 2026
VA State Medical License 2011 - 2026
IL State Medical License 2007 - 2017
American Board of Allergy and Immunology Allergy & Immunology
American Board of Internal Medicine Internal Medicine
Clinical Trials
- Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and Infants Start of enrollment: 2011 Sep 01
- Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents Start of enrollment: 2014 Jul 22
- Safety and Immunogenicity of High-Dose Quadrivalent Influenza Vaccine in Patients ≥65 Years Start of enrollment: 2017 Sep 15
Publications & Presentations
PubMed
- 15 citationsEfficacy and safety of sipavibart for prevention of COVID-19 in individuals who are immunocompromised (SUPERNOVA): a randomised, controlled, double-blind, phase 3 trial.Ghady Haidar, Steven Thomas, Paul Loubet, Ross I Baker, Thomas Benfield
The Lancet. Infectious Diseases. 2025-07-01 - 19 citationsAZD3152 neutralizes SARS-CoV-2 historical and contemporary variants and is protective in hamsters and well tolerated in adults.Yingyun Cai, Seme Diallo, Kim Rosenthal, Kuishu Ren, Daniel J Flores
Science Translational Medicine. 2024-06-26 - 7 citationsSuperior immunogenicity of high-dose quadrivalent inactivated influenza vaccine versus Standard-Dose vaccine in Japanese Adults ≥ 60 years of age: Results from a phase...Leilani Sanchez, Takahiro Nakama, Hideaki Nagai, Osamu Matsuoka, Satoshi Inoue
Vaccine. 2023-04-06
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
